Happy Hour難得聊正經題目。FDA在2/17通過Iovance的Amtagvi，是第一個針對固態腫瘤（solid tumor）的T-cell療法。這個療法為什麼重要？Tumor-infiltrating lymphocytes（TIL）又是什麼呢？來聽聽看若晴怎麼說。 大家要去聽新手村跟新的集數捏 若晴說她沒用ptt啦… 被生成式AI洗版（都快變洗臉了） TIL為什麼可以搞定黑色素瘤？ 現在市面上T細胞治療有哪些？ 是不是可割可棄很重要 為什麼固態腫瘤很棘手？ 不意外價錢美金六位數 難道TIL只能從腫瘤拿出來？ 多多保重身體多做檢查 -- Hosting provided by SoundOn
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast